SCHEMBL6163040

SCHEMBL6163040

NC(=O)C1SCCN1C(=O)[CH]Cc1ccccc1

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 1/20 0.36
CYP2C19 P33261 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
FAAH O00519 1/20 0.35
CFD P00746 1/20 0.34
GAA P10253 2/20 0.34
TACR1 P25103 1/20 0.34
ALDH1A1 P00352 2/20 0.33
SIRT1 Q96EB6 1/20 0.33
CYP2C9 P11712 1/20 0.32
DPP4 P27487 1/20 0.32
DPP8 Q6V1X1 1/20 0.32
DPP9 Q86TI2 1/20 0.32
DPP7 Q9UHL4 1/20 0.32
LMNA P02545 1/20 0.32
ACE P12821 1/20 0.32
KCNA5 P22460 1/20 0.32
PREP P48147 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6161261 0.86 CFD (0.44) CFDALDH1A1LMNA
SCHEMBL6162964 0.83 DPP7 (0.43) FAAHCFDSIRT1DPP4DPP8
SCHEMBL6167323 0.83 LMNA (0.44) CYP2C19CFDALDH1A1SIRT1LMNA
SCHEMBL6162718 0.83 CFD (0.40) CYP2C19CFDALDH1A1SIRT1DPP4
SCHEMBL6350305 0.80 ACE (0.37) RIPK1CYP2C19SMN1; SMN2FAAHCFD
SCHEMBL3137610 0.80 CNR2 (0.39) CYP2C19SMN1; SMN2GAATACR1DPP4
SCHEMBL3138570 0.75 SPHK1 (0.50) DPP4DPP8DPP9DPP7ACE
SCHEMBL4086816 0.74 TACR1 (0.44) CYP2C19SMN1; SMN2CFDGAATACR1
SCHEMBL4095230 0.74 TACR1 (0.44) CYP2C19SMN1; SMN2CFDGAATACR1
SCHEMBL6163270 0.74 SPHK1 (0.47) ALDH1A1DPP4ACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1134213-B1 Process for the preparation of substituted N-(indole-2-carbonyl)- glycinamides PFIZER (US) 2005-11-02 EP disclosed
EP-0832065-B1 SUBSTITUTED N-(INDOLE-2-CARBONYL)-GLYCINAMIDES AND DERIVATIVES AS GLYCOGEN PHOSPHORYLASE INHIBITORS PFIZER (US) 2001-10-10 EP disclosed
EP-1134213-A2 Process for the preparation of substituted N-(indole-2-carbonyl)- glycinamides PFIZER INC. (US) 2001-09-19 EP disclosed
US-6277877-B1 GLYCOGEN PHOSPHORYLASE INHIBITOR; ANTIDIABETIC AGENTS PFIZER, INC. 2001-08-21 US disclosed
US-6107329-A HYPOTENSIVE AGENTS; CARDIOVASCULAR DISORDERS PFIZER, INC. (US) 2000-08-22 US disclosed
EP-0832065-A1 SUBSTITUTED N-(INDOLE-2-CARBONYL)-GLYCINAMIDES AND DERIVATIVES AS GLYCOGEN PHOSPHORYLASE INHIBITORS PFIZER INC. (US) 1998-04-01 EP disclosed
WO-1996039384-A1 SUBSTITUTED N-(INDOLE-2-CARBONYL)-GLYCINAMIDES AND DERIVATIVES AS GLYCOGEN PHOSPHORYLASE INHIBITORS PFIZER, INC. (US) 1996-12-12 WO disclosed